SABCS 2022 Conference Coverage

 

SABCS 2022 Conference Coverage
Avatar

SABCS 2022 Correlative Analysis From NeoPACT and NeoSTOP Trials: Association of TNBC-DX Scores With Outcomes in TNBC Treated With Neoadjuvant Pembro and Chemo

By SABCS 2022 Conference Coverage FEATURING Priyanka Sharma
By SABCS 2022 Conference Coverage FEATURING Priyanka Sharma
123 views
December 13, 2022
0 Comments
Login to view comments. Click here to Login
Videos
09:01
SABCS 2022 Conference Coverage

Adjuvant Treatment for HR+/HER2-, Node-Positive, High-Risk eBC: 4-Ye…

Feat. W. Mchayleh
11:09
SABCS 2022 Conference Coverage

SABCS 2022 Results From a Pre-Planned monarchE OS Interim Analysis, …

Feat. J. Huober
22:22
SABCS 2022 Conference Coverage

SABCS 2022 Genomic Analysis of ctDNA From Patients With HR+, HER2-Mu…

Feat. C. Ma
06:10
SABCS 2022 Conference Coverage

SABCS 2022: The Effect of Race on Pathologic Complete Response Rates…

Feat. H. Woriax
12:44
SABCS 2022 Conference Coverage

SABCS 2022 Primary Results From the Randomized Phase II RIGHT Choice…

Feat. Y. Lu
06:42
SABCS 2022 Conference Coverage

SABCS 2022 Long-Term Survival of the GeparOLA Study: Neoadjuvant Pac…

Feat. P. Fasching
27:50
SABCS 2022 Conference Coverage

SABCS 2022 Beyond Anthracyclines and Trastuzumab: Cardiotoxicity of …

Feat. S. Dent
10:47
SABCS 2022 Conference Coverage

SABCS 2022 Population-Based Estimates of Contralateral BC Risk Among…

Feat. S. Yadav
04:21
SABCS 2022 Conference Coverage

SABCS 2022 on the OPHELIA Study: Olaparib + Trastuzumab in HER2+ BRC…

Feat. J. Martínez
11:09
SABCS 2022 Conference Coverage

SABCS 2022 Primary Results of the Randomized Phase 3 DESTINY-Breast0…

Feat. I. Krop
07:32
SABCS 2022 Conference Coverage

SABCS 2022 Early TNBC Treated With Neoadjuvant Chemo: Association of…

Feat. D. Krug
15:23
SABCS 2022 Conference Coverage

SABCS 2022 Primary Results From the POSITIVE Trial (IBCSG 48-14 / BI…

Feat. H. Azim
08:39
SABCS 2022 Conference Coverage

SABCS 2022 Tumor-Agnostic Measurement of ctDNA Levels With mFAST-Seq…

Feat. N. Verschoor
07:39
SABCS 2022 Conference Coverage

SABCS 2022 Post-Neoadjuvant Therapy in TNBC: To Clip or Not to Clip

Feat. V. Galimberti
13:46
SABCS 2022 Conference Coverage

SABCS 2022 TROPiCS-02 Phase 3 Study of Patients With HR+/HER2- mBC: …

Feat. H. Rugo
07:41
SABCS 2022 Conference Coverage

SABCS 2022 DETECT V Phase 3 Trial: Omission of Chemo in the Treatmen…

Feat. W. Janni
07:15
SABCS 2022 Conference Coverage

SABCS 2022: CBD Oil - A Potential Solution in Case of Severe Tamoxif…

Feat. S. Buijs
05:38
SABCS 2022 Conference Coverage

SABCS 2022: Correlating Predicted Adjuvant Therapy Benefit and Risk …

Feat. R. Patel
02:16
SABCS 2022 Conference Coverage

SABCS 2022 Phase 2 Expansion (VERITAC) of a Phase 1/2 Study: ARV-471…

Feat. E. Hamilton
10:47
SABCS 2022 Conference Coverage

SABCS 2022 Dose-Expansion Study DESTINY-Breast07: T-DXd as Monothera…

Feat. E. Hamilton
19:54
SABCS 2022 Conference Coverage

SABCS 2022 Hormonal Exposures and Cancer Risk in BRCA1/2 Mutation Ca…

Feat. J. Kotsopoulos
05:34
SABCS 2022 Conference Coverage

SABCS 2022 Identifying Drivers of 1L HR+/HER2- mBC Treatment Choices

Feat. A. Brufsky
06:45
SABCS 2022 Conference Coverage

SABCS 2022 Post Hoc Analysis of Adjuvant RT in the Phase 3 KEYNOTE-5…

Feat. H. McArthur
13:17
SABCS 2022 Conference Coverage

SABCS 2022 Post Neoadjuvant Therapy in TNBC

Feat. H. McArthur
07:30
SABCS 2022 Conference Coverage

SABCS 2022 Impact of Adjuvant ET Omission in ER+ BC Treated With Neo…

Feat. G. Choong
12:42
SABCS 2022 Conference Coverage

SABCS 2022 Multicenter Retrospective ROSET-BM Study: T-DXd for the T…

Feat. Y. Takashi
05:36
SABCS 2022 Conference Coverage

SABCS 2022 Breast Preservation After Local Recurrence of BC: Compari…

Feat. H. Kolberg
04:44
SABCS 2022 Conference Coverage

SABCS 2022 Molecular Fluorescence-Guided Surgery Using BEVA800 for t…

Feat. H. Kolberg
07:24
SABCS 2022 Conference Coverage

SABCS 2022 Comparison of a Mono Atezo Window Followed by Atezo &…

Feat. H. Kolberg
19:57
SABCS 2022 Conference Coverage

SABCS 2022 Challenging Types of Breast Cancer: Lobular/Pleomorphic

Feat. S. Loibl
05:50
SABCS 2022 Conference Coverage

SABCS 2022 PENELOPE-B and PALLAS Trials: Development and Validation …

Feat. S. Loibl
05:45
SABCS 2022 Conference Coverage

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC:…

Feat. S. Tolaney
02:31
SABCS 2022 Conference Coverage

SABCS 2022 Phase 3 TROPiCS-02 Study: Exposure-Adjusted Incidence Rat…

Feat. S. Tolaney
12:21
SABCS 2022 Conference Coverage

SABCS 2022 Phase 3 Randomized Controlled Trial: Addition of Platinum…

Feat. S. Gupta
10:25
SABCS 2022 Conference Coverage

SABCS 2022 Biology and Clinical Course of Lobular Cancer in BC

Feat. R. Layman
06:48
SABCS 2022 Conference Coverage

SABCS 2022: PgR Levels & Ki67 Expression of Lobular Carcinomas o…

Feat. C. Markopoulos
10:52
SABCS 2022 Conference Coverage

SABCS 2022 Patient-Reported Cognitive Impairment in Women Participat…

Feat. I. Kang
16:23
SABCS 2022 Conference Coverage

SABCS 2022 Immune Landscape and Microenvironments in BC

Feat. M. Ignatiadis
16:49
SABCS 2022 Conference Coverage

SABCS 2022 Inflammatory Breast Cancer: A Perfect Storm

Feat. F. Lynce
06:37
SABCS 2022 Conference Coverage

SABCS 2022 High PD-L2 Protein Expression in Cancer Cells Is an Indep…

Feat. L. Chaudhary
10:17
SABCS 2022 Conference Coverage

SABCS 2022 Clinical Use of Breast Cancer Index for Prediction of Lat…

Feat. V. Dabak
20:32
SABCS 2022 Conference Coverage

SABCS 2022: Enhancing the Effects of Immunotherapy in Metastatic Bre…

Feat. M. Gatti-Mays
07:48
SABCS 2022 Conference Coverage

SABCS 2022: Real-World 2L Treatment Patterns and Associated Clinical…

Feat. K. Clifton
04:32
SABCS 2022 Conference Coverage

SABCS 2022 Phase 3 TAILORx Breast Cancer Trial: 21-Gene Recurrence S…

Feat. S. Yang
11:42
SABCS 2022 Conference Coverage

SABCS 2022: Trastuzumab-Induced Tumor Microenvironment Changes in Ea…

Feat. L. Kennedy
12:00
SABCS 2022 Conference Coverage

SABCS 2022 CDK4/6 Inhibitors: Are They All the Same or Different?

Feat. D. Patt
10:01
SABCS 2022 Conference Coverage

SABCS 2022 Results of the Randomized, Multi-Dose Phase 2 SERENA-2 Tr…

Feat. M. Oliveira
10:10
SABCS 2022 Conference Coverage

SABCS 2022 Results from ACOSOG Z11102 (Alliance): Impact of Breast C…

Feat. J. Boughey
14:58
SABCS 2022 Conference Coverage

SABCS 2022 Poster Reviews of Special Populations: Male Breast Cancer

Feat. J. Pablo Leone
09:13
SABCS 2022 Conference Coverage

SABCS 2022 Predictors of Response to Neoadjuvant Chemo in Breast Can…

Feat. N. Bilani
13:17
SABCS 2022 Conference Coverage

SABCS 2022 Chemotherapy-Induced Cardio Toxicity: The Patient Experie…

Feat. A. Gaffney-Adams
12:02
SABCS 2022 Conference Coverage

SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen …

Feat. A. De Censi
14:28
SABCS 2022 Conference Coverage

SABCS 2022 EMERALD Phase 3 Trial Updated Results by Duration of Prio…

Feat. H. Khong
18:43
SABCS 2022 Conference Coverage

SABCS 2022 Antibody Drug Conjugates for TNBC

Feat. L. Ellisen
13:05
SABCS 2022 Conference Coverage

SABCS 2022 Stromal Tumor-Infiltrating Lymphocytes Identify Early-Sta…

Feat. R. Leon Ferre
12:54
SABCS 2022 Conference Coverage

SABCS 2022 Phase III SWOG S1207 Trial: Evaluating Adjuvant ET +/- 1 …

Feat. M. Mac Gregor
09:40
SABCS 2022 Conference Coverage

SABCS 2022 Updated Survival Results of the Randomized Phase 3 Study …

Feat. S. Hurvitz
08:25
SABCS 2022 Conference Coverage

SABCS 2022 Race & Clinical Outcomes in the RxPONDER Trial (SWOG …

Feat. Y. Abdou
05:53
SABCS 2022 Conference Coverage

SABCS 2022 Patient-Reported Outcomes From the TROPiCS-02 Trial: The …

Feat. F. Marmé
25:01
SABCS 2022 Conference Coverage

SABCS 2022: FLASH-RT, Ultra-High Dose Rate Rate Radiotherapy, Is as …

Feat. F. Dirbas
04:35
SABCS 2022 Conference Coverage

SABCS 2022 5-Year Results and Correlative Analyses From ATEMPT (TBCR…

Feat. P. Tarantino
03:14
SABCS 2022 Conference Coverage

SABCS 2022: Comprehensive Genomic Characterization of HER2-Low Breas…

Feat. P. Tarantino
06:54
SABCS 2022 Conference Coverage

SABCS 2022 Correlative Analysis From NeoPACT and NeoSTOP Trials: Ass…

Feat. P. Sharma
06:51
SABCS 2022 Conference Coverage

SABCS 2022: Genomic and Transcriptomic Landscape of HER2-Low Breast …

Feat. R. Bansal
10:46
SABCS 2022 Conference Coverage

SABCS 2022 on a Randomized Phase II PACE (Palbociclib After CDK4/6i …

Feat. E. Mayer
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
08:33
SABCS 2022 Conference Coverage

SABCS 2022 Validation of Profile for the Omission of Local Adjuvant …

Feat. P. Karlsson
03:02
SABCS 2022 Conference Coverage

SABCS 2022 Clinical and Molecular Characteristics of HER2-Low/Zero E…

Feat. C. Yam
08:15
SABCS 2022 Conference Coverage

SABCS 2022 Absence of Lobular Carcinoma in Situ, a Poor Prognostic M…

Feat. J. Mouabbi